← Open Payments lookup

GUSS GRIMMETT: Open Payments

NPI 1881620730 · BLACKFOOT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$723 in 50 payments from 15 companies in 2025. Trend: 2023 $487 · 2024 $677 · 2025 $723

Food & beverage: $723
CompanyPaymentsAmount
ABBVIE INC.23$267
Axsome Therapeutics, Inc.4$63
Lilly USA, LLC4$63
Insulet Corporation2$56
Novartis Pharmaceuticals Corporation2$42
Phathom Pharmaceuticals, Inc.3$42
GlaxoSmithKline, LLC.2$35
Astellas Pharma US Inc1$30
Novo Nordisk Inc2$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23

Products named: VRAYLAR, QULIPTA, Auvelity, Omnipod, MOUNJARO, LEQVIO, VOQUEZNA, TRELEGY ELLIPTA.

Industry payments across ID — which companies pay providers there.